Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients

Adjuvant radiotherapy has no benefit following radical prostatectomy

Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC

Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Myeloma treatment and prognosis

How to approach a breast lump and nipple discharge

Remote access thyroid surgery

Imaging and intervention in thyroid lesions

Axillary management in breast

Modified radical mastectomy

Cost-benefit analysis of new cancer medicines: The difficult choices of governments